Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in Southern Pakistani patients

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Iqbal, Mehr Un Nisa ^a   Khan, Taseer Ahmed ^a   Maqbool, Syed Amir ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b Karachi Institute of Radiotherapy & Nuclear Medicine   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CDX2 PROTEIN, HUMAN; DNA; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR CDX2;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PAKISTAN; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BREAST TUMOR; COHORT ANALYSIS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; ODDS RATIO; PATHOLOGY; RETROSPECTIVE STUDY; RISK; TERTIARY CARE CENTER;

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CDX2 TRANSCRIPTION FACTOR; COHORT STUDIES; DNA; FEMALE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; ODDS RATIO; PAKISTAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES; RISK; TERTIARY CARE CENTERS;

EID: 84925815443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122657     Document Type: Article

References (66)

1. Pakistan Medical Research Council (1977) Collection of data of various types of tumors in Pakistan. (PMRC Monograph No. 1). Karachi: PMRC.
2. Hanif M, Zaidi P, Kamal S, Hameed A (2009) Institution-based Cancer Incidence in a Local Population in Pakistan: Nine Year Data Analysis. Asian Pacific J. Cancer Prev. 10, 227-230. PMID: 19537889
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343(2):78-85. doi: 10.1056/NEJM200007133430201 PMID: 10891514
4. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al (2010) Performance of common genetic variants in breast cancer risk models. N Engl J Med, 362(11):986-993. doi: 10.1056/NEJMoa0907727 PMID: 20237344
5. Harris TJ, McCormick F (2010) The molecular pathology of cancer. Nat Rev Clin Oncol, 7:251-265. doi: 10.1038/nrclinonc.2010.41 PMID: 20351699
6. Cheung KL (2007) Endocrine therapy for breast cancer: an overview. Breast, 16 (4):327-343. doi: 10.1016/j.breast.2007.03.004 PMID: 17499991
7. Silva IS, De-Stavola B, McCormack V (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. doi: 10.1371/journal.pmed.0050193.
8. Zaman K, Bodmer A, Pralong F, Castiglione-Gertsch M (2012) Breast cancer and obesity, a dangerous relation. Rev Med Suisse, 8(342):1101-1104. PMID: 22734178
9. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, et al (2004) Body mass index as a prognostic feature inoperable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol, 15(6):875-884. PMID: 15151943
10. Hankinson SE (2008) Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer. Adv Exp Med Biol, 617:161-169. doi: 10.1007/978-0-387-69080-3-15 PMID: 18497040
11. Malik F A, Ashraf S, Kayani A, Jiang WG, Mir A, Ansar M, et al., (2008) Contribution of BRCA1 germline mutation in patients with sporadic breast cancer. International Seminars in Surgical Oncology, vol. 5, published online. doi: 10.1186/1477-7800-5-21
12. Rashid MU1, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, et al., (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. International Journal of Cancer, vol. 119(12): 2832-2839. PMID: 16998791
13. Liede A, Malik IA, Aziz Z, De los Rios P, Kwan E, Narod SA (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. American Journal of Human Genetics, vol. 71(3): 595-606. PMID: 12181777
14. Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. JNatl Cancer Inst. 102:680-691. doi: 10.1093/jnci/djq088 PMID: 20427433
15. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S (2010) Breast tissue composition and susceptibility to breast cancer. J NatlCancer Inst, 102:1224-1237. doi: 10.1093/jnci/djq239 PMID: 20616353
16. Krishnan AV, Swami S, Feldman D (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol, 121(1-2):343-8. doi: 10.1016/j.jsbmb.2010.02.009
17. Plum LA, DeLuca HF (2010) Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov, 9:941-955. doi: 10.1038/nrd3318 PMID: 21119732
18. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7:684-700. PMID: 17721433
19. McCullough ML, Bostick RM, Mayo TL (2009) Vitamin D Gene Pathway Polymorphisms and Risk of Colorectal, Breast, and Prostate Cancer. Annual Review of Nutrition, 29: 111-132. doi: 10.1146/annurev-nutr-080508-141248 PMID: 19400699
20. Imtiaz S, Siddiqui N, Raza SA, Loya A, Muhammad A (2012) Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocr Metab 16:409-413.
21. Bertone-Johnson ER (2009) Vitamin D and breast cancer. Ann Epidemiol, 19:462-467. doi: 10.1016/j.annepidem.2009.01.003 PMID: 19230714
22. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, et al (2005) Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res, 11(9):3579-86. doi: 10.1158/1078-0432.CCR-04-2359 PMID: 15867263
23. Zmuda JM, Cauley JA, Ferrell RE (2000) Molecular Epidemiology of Vitamin D Receptor Gene Variants. Epidemiologic Reviews, 22 (2): 203-217. PMID: 11218372
24. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, et al. (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer, 10:483. doi: 10.1186/1471-2407-10-483 PMID: 20831823
25. Tang C, Chen N, Wu M, Yuan H, Du Y (2009) Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117:391-399. doi: 10.1007/s10549-008-0262-4 PMID: 19145484
26. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, et al. (2012) Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol. Biomarkers Prev. 21 (10): 1856-1867. doi: 10.1158/1055-9965.EPI-12-0551 PMID: 22892281
27. Anderson LN, Cotterchio M, Cole DE, Knight JA (2011) Vitamin D related genetic variants, interactions with vitamin D exposure, and breast cancer risk among caucasian women in ontario. Cancer Epidemiol Biomarkers Prev, 20:1708-1717. doi: 10.1158/1055-9965.EPI-11-0300 PMID: 21693626
28. Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, Manjeshwar S, et al. (2011) Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J. Am. Coll. Surg. 215 (5): 652-657. doi: 10.1016/j.jamcollsurg.2012.06.413 PMID: 22867716
29. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, Byers T, et al. (2011) Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U. S. Breast Cancer Res. Treat. 132 (2): 683-691. doi: 10.1007/s10549-011-1885-4 PMID: 22130867
30. Yang B, Liu S, Yang X, Wangc Y, Zhao X, Zheng D, et al. (2014) Current evidence on the four polymorphisms of VDR and breast cancer risk in Caucasian women. Meta Gene 2: 41-49. doi: 10.1016/j.mgene.2013.09.008 PMID: 25606388
31. Zhang K, Song L (2014) Association between Vitamin D Receptor Gene Polymorphisms and Breast Cancer Risk: A Meta-Analysis of 39 Studies. PLoS ONE 9(4): e96125. doi: 10.1371/journal.pone.0096125 PMID: 24769568
32. Shahbazi S, Alavi S, Majidzadeh-A K, Ghaffarpour M, Soleimani A, Mahdian R (2013) BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med. Oncol. 30,393. doi: 10.1007/s12032-012-0393-7 PMID: 23277283
33. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. (2004) Vitamin D receptor gene polymorphisms and breast cancer risk. Clin. Cancer Res. 10, 5472-5481. PMID: 15328186
34. Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, et al. (2001) The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res, 16:1256-1264 PMID: 11450701
35. Brown MA, Haughton MA, Grant SF, Gunnell AS, Henderson NK, Eisman JA (2001) Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and vitamin D receptor genes. J Bone Miner Res, 14: 758-764.
36. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, et al. (2012) Variants in the vitamin D pathway, serum levels of vitamin D, andestrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res, 14:R58. doi: 10.1186/bcr3162 PMID: 22480149
37. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res, 10 (2): R31. doi: 10.1186/bcr1994 PMID: 18419802
38. Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, Inoue Y, et al. (1999) The caudal-related homeodomainCdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Minar Res, 14: 240-247.
39. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA and VanLeeuwen JP (2004) Genetics and biology of vitaminD receptor polymorphisms. Gene, 338: 143-156. PMID: 15315818
40. Zhou ZC, Wang J, Cai ZH, Zhang QH, Cai ZX, Wu JH et al. (2013) Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility. TumourBiol, 34(6):3437-41. doi: 10.1007/s13277-013-0919-4 PMID: 23821301
41. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Dujin CM, van Leeuwen JP, et al. (2003) Cdx-2polymorphism in the promoter region of the human vitamin Dreceptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res, 18: 1632-1641. PMID: 12968672
42. Marozik P, Mosse I, Alekna V, Rudenko E, Tamulaitiene M, Ramanau H, et al. (2013) Association between Polymorphisms of VDR, COL1A1, and LCT Genes and Bone Mineral Density in Belarusian Women with Severe Postmenopausal Osteoporosis. Medicina (Kaumas), 49(4):20-26.
43. Jiao Z, Li D (2013) Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies. Tumour Biol, 34:1225-1233. doi: 10.1007/s13277-013-0665-7 PMID: 23393023
44. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med, 155:827-838. doi: 10.7326/0003-4819-155-12-201112200-00005 PMID: 22184690
45. Mondul AM, Weinstein SJ, Horst RL, Purdue M, Albanes D (2012) Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial. Cancer Epidemiol Biomarkers Prev, 21:1222-1225. doi: 10.1158/1055-9965.EPI-12-0439 PMID: 22623707
46. Chen L, Davey SG, Evans DM, Cox A, Lawlor DA, Donovan J, et al. (2009) Genetic variants in the vitamin D receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev, 18:2874-2881. doi: 10.1158/1055-9965.EPI-09-0544 PMID: 19861519
47. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 20:1003-1016. doi: 10.1158/1055-9965.EPI-10-1141 PMID: 21378269
48. Chen WY, Bertone-Johnson E R, Hunter D J, Willett WC, Hankinson S E (2005) Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2335-2339. PMID: 16214913
49. Trabert B, Malone K E, Daling J R, Doody DR, Bernstein L, Ursin G, et al (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 9: R84. PMID: 18067661
50. Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, et al (2004) Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics. 14: 239-245. PMID: 15083068
51. Horwitz KB, McGuire WL (1975) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science, 189:726-727. PMID: 168640
52. Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen B, et al. (2012) Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol 18: 1672-1679. doi: 10.3748/wjg.v18.i14.1672 PMID: 22529698
53. Yin M, Wei S, Wei Q (2009) Vitamin D Receptor Genetic Polymorphisms and Prostate Cancer Risk: A Meta-analysis of 36 Published Studies. Int J Clin Exp Med. 2: 159-175. PMID: 19684888
54. John E M, Schwartz GG, Koo J, Van Den Berg D, Ingles SA (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 65: 5470-5479. doi: 10.1158/0008-5472.can-04-3134 PMID: 15958597
55. Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, De Bolós C, David L. et al (2003) Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol, 199:36-40. PMID: 12474224
56. Mutoh H, Sakurai S, Satoh K, et al (2004) Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res, 64:7740-7747. PMID: 15520178
57. Kang JM, Lee BH, Kim N, Lee HS, Lee HE, Park JH, et al (2011) CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci, 26: 647-653. doi: 10.3346/jkms.2011.26.5.647 PMID: 21532856
58. Bai YQ, Yamamoto H, Akiyama Y, Swain GP, Moffett J, Sund NJ, Set al (2002) Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett, 8: 47-55.
59. Bonhomme C, Duluc I, Martin E, Chawengsaksophak K, Chenard MP, Kedinger M, et al (2003) The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut, 52: 1465-1471. PMID: 12970140
60. Qin R, Wang NN, Chu J, Wang X (2012) Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions. World J Gastroenterol, 18: 3296-3302. doi: 10.3748/wjg.v18.i25.3296 PMID: 22783055
61. Miyamoto K, Kesterson R A, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, et al. (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endcrinol. 11:1165-1179.
62. Campbell M J, Gombart A F, Kwok S H, Park S, Koeffler H P (2000) The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene. 19:5091-5097. PMID: 11042697
63. Zinser G M, Welsh J (2004) Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis. 25: 2361-2372. PMID: 15333467
64. Zinser G M, Sundberg J P, Welsh J (2002) Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 23: 2103-2109. PMID: 12507934
65. Matsumoto H, Iino Y, Koibuchi Y, Andoh T, Horii Y, Takei H, et al. (1999) Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice. Oncol Rep. 6:349-352. PMID: 10023003
66. Gonzalez-Sancho J M, Alvarez-Dolado M, Munoz A (1998) 1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells. FEBS Lett. 426:225-228. PMID: 9599013